Chewy Shows Strong Growth in Q3, Expands Market Share
Chewy beats earnings and revenue expectations in Q3, with growing profits, active customers, and expanding market share.
Already have an account? Sign in.
Chewy beats earnings and revenue expectations in Q3, with growing profits, active customers, and expanding market share.
FDA plans to restrict non-approved compounded GLP-1 drugs sold by Hims & Hers and compounding pharmacies, citing safety concerns and misleading marketing practices.
DraftKings (DKNG) partners with Crypto.com to expand prediction markets, adding player-specific sports contracts and new categories including politics and entertainment.
Analysts say Pfizer listing Chantix on TrumpRx may support Achieve Life Sciences and boost confidence in cytisinicline’s approval prospects.